Skip to main content
Atrás
MTD logo

Mettler-Toledo International Inc.

Calidad de datos: 100%
MTD
NYSE Healthcare Medical - Diagnostics & Research
$1,265.75
▲ $1.29 (0.10%)
Cap. Mercado: 25.73B
Rango del Día
$1,248.06 $1,299.99
Rango de 52 Semanas
$946.69 $1,525.17
Volumen
95,692
Promedio 50D / 200D
$1,353.91 / $1,321.41
Cierre Anterior
$1,264.46

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica Acción Mediana del Sector
P/E 29.6 0.3
P/B — 3.0
ROE % — 3.7
Net Margin % 21.6 3.8
Rev Growth 5Y % 2.0 10.0
D/E — 0.2

Precio Objetivo de Analistas

Hold
$1,485.00 +17.3%
Low: $1,400.00 High: $1,600.00
P/E Futuro
27.22
EPS Futuro
$46.50
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
4.23B

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2030 $68.32
$67.48 – $68.97
 5.09B 1
FY2029 $62.62
$61.84 – $63.22
 4.92B 1
FY2028 $56.93
$56.06 – $57.87
 4.68B 3

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-05 $12.80 $13.36 +4.4%
2025-11-06 $10.66 $11.15 +4.6%
2025-07-31 $9.60 $10.09 +5.1%
2025-05-01 $7.88 $8.19 +3.9%
2025-02-06 $11.72 $12.41 +5.9%
2024-11-08 $10.01 $10.21 +2.0%
2024-08-01 $9.03 $9.65 +6.9%
2024-05-09 $7.64 $8.89 +16.4%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 2.01% annually over 5 years — modest growth
Net margin of 21.59% shows strong profitability
Generating 848.65M in free cash flow
Cash machine — converts 97.64% of earnings into free cash flow
Capital efficient — spends only 2.66% of revenue on capex
ROIC of 36.16% — excellent capital efficiency

Crecimiento

Revenue Growth (5Y)
2.01%
Revenue (1Y)3.98%
Earnings (1Y)0.70%
FCF Growth (3Y)-0.69%

Calidad

Return on Equity
N/A
ROIC36.16%
Net Margin21.59%
Op. Margin27.78%

Seguridad

Debt / Equity
N/A
Current Ratio1.14
Interest Coverage16.32

Valoración

P/E Ratio
29.60
Forward P/E27.22
P/B RatioN/A
EV/EBITDA25.04
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 3.98% Revenue Growth (3Y) 3.09%
Earnings Growth (1Y) 0.70% Earnings Growth (3Y) 4.97%
Revenue Growth (5Y) 2.01% Earnings Growth (5Y) 3.11%
Profitability
Revenue (TTM) 4.03B Net Income (TTM) 869.19M
ROE N/A ROA 23.41%
Gross Margin 57.52% Operating Margin 27.78%
Net Margin 21.59% Free Cash Flow (TTM) 848.65M
ROIC 36.16% FCF Growth (3Y) -0.69%
Safety
Debt / Equity N/A Current Ratio 1.14
Interest Coverage 16.32
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 29.60 Forward P/E 27.22
P/B Ratio N/A P/S Ratio 6.39
PEG Ratio 8.96 Forward PEG N/A
EV/EBITDA 25.04 Fwd EV/EBITDA 20.90
Forward P/S 6.08 Fwd Earnings Yield 3.67%
FCF Yield 3.30%
Market Cap 25.73B Enterprise Value 28.00B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.03B 3.87B 3.79B 3.92B 3.72B
Net Income 869.19M 863.14M 788.78M 872.50M 768.99M
EPS (Diluted) 42.17 40.67 35.90 38.41 32.78
Gross Profit 2.32B 2.25B 2.17B 2.24B 2.11B
Operating Income 1.12B 1.13B 1.08B 1.13B 994.74M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.71B 3.24B 3.36B 3.49B 3.33B
Total Liabilities 3.74B 3.37B 3.51B 3.47B 3.16B
Shareholders' Equity -23.64M -126.89M -149.94M 24.79M 171.42M
Total Debt 2.34B 2.13B 2.20B 2.13B 1.80B
Cash & Equivalents 66.89M 59.36M 69.81M 95.97M 98.56M
Current Assets 1.36B 1.19B 1.23B 1.38B 1.27B
Current Liabilities 1.20B 1.17B 1.18B 1.15B 1.15B